![](/img/cover-not-exists.png)
Cytogenetic and clinical marks for defining high-risk myeloma in the context of bortezomib treatment
An, Gang, Acharya, Chirag, Deng, Shuhui, Yi, Shuhua, Xu, Yan, Qin, Xiaoqi, Sui, Weiwei, Li, Zengjun, Shi, Lihui, Zang, Meirong, Feng, Xiaoyan, Hao, Mu, Zou, Dehui, Zhao, Yaozhong, Qi, Junyuan, Cheng,Volume:
43
Language:
english
Journal:
Experimental Hematology
DOI:
10.1016/j.exphem.2014.11.004
Date:
March, 2015
File:
PDF, 1.77 MB
english, 2015